Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update, Issue 11

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 11 (PDF).

This issue includes the following drug safety advice articles:

  • Natalizumab (Tysabri): safety overview—progressive multifocal leukoencephalopathy, hypersensitivity, and hepatotoxicity
  • Nicorandil: gastrointestinal ulceration

In addition, this issue contains a hot topic containing information about
recent data from the ENHANCE trial and also a stop press warning that several herbal products available for erectile dysfunction have been found to contain prescription only drugs including oral hypoglycaemic agents.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update, Issue 11' on Email Share 'Drug Safety Update, Issue 11' on Delicious Share 'Drug Safety Update, Issue 11' on Digg Share 'Drug Safety Update, Issue 11' on Facebook Share 'Drug Safety Update, Issue 11' on Google+ Share 'Drug Safety Update, Issue 11' on reddit Share 'Drug Safety Update, Issue 11' on StumbleUpon Share 'Drug Safety Update, Issue 11' on Twitter

atomic-wealth

No Comments to “Drug Safety Update, Issue 11”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,523 spam comments.

atomic-wealth
fond-illness
summer